Stocks were indicated lower on Tuesday, but this was due to international tensions after Turkey blew a Russian fighter jet out of the sky. This will likely be a thinner volume and lower analyst coverage week after Tuesday due to the departures and absences around the Thanksgiving holiday. as a reminder — one trend that has been static for over 4 years now is that investors keep proving they want to buy stocks on weakness or on strength.
24/7 Wall St. reviews dozens of analyst reports each day of the week. The aim is to find new investing and trading ideas for its readers. Some of the analyst reports cover stocks to buy, while other calls cover stocks to sell or stock to avoid. These are this Tuesday’s top analyst upgrades, downgrades and initiations.
Avon Products Inc. (NYSE: AVP) was raised to Buy from Neutral with a $5.00 price target (versus $2.85 close) at Citigroup. Avon had a consensus analyst price target of $4.52 and has a 52-week range of $2.41 to $10.20.
Brocade Communications Systems, Inc. (NASDAQ: BRCD) was downgraded to Neutral from Overweight at JPMorgan. Brocade shares were lower by 8% at $9.25 after earnings and guidance disappointed. Brocade’s prior 52-week range was $9.67 to $12.96.
Emerge Energy Services LP (NYSE: EMES) was raised to Hold from Sell at Stifel. Emerge rose 6.3% to $6.08 on Monday and it has a 52-week range of $3.78 to $82.45.
GameStop Corp. (NYSE: GME) was downgraded to Neutral from Buy with a 442 price objective (versus $37.61 close, after a 4.2% drop on Monday) at Bank of America Merrill Lynch. Oppenheimer downgraded GameStop to Perform from Outperform.
Infoblox Inc. (NYSE: BLOX) was downgraded to Sell from Hold and the price target was cut to $13 from $20 (versus $15.74 close, but it is indicated down 9% at $14.25 on Tuesday).
Kinross Gold Corp. (NYSE: KGC) was raised to Sector Perform from Underperform with a $2.50 price target (versus $1.75 close) at RBC Capital Markets. Kinross has a $2.52 consensus price target and a 52-week range of $1.35 to $3.71.
Teladoc, Inc. (NYSE: TDOC) was started as Outperform with a $31 price target (versus $19.28 close) at Oppenheimer. Teladoc has a post-IPO range of $15.32 to $35.42.
Other key analyst upgrades and downgrades from this Tuesday were in shares of the following companies: